Reproductive & Genetic Hospital of CITIC-XIANGYA
Changsha, Hunan, 410008, China
NCT Number: NCT04639505
In China, the incidence of infertility is about 15%, and patients need to use assisted reproductive technology (ART) to obtain pregnancy. It is particularly important to accurately predict the patient's ovarian response before initiating controlled ovulation hyperstimulation (COH). At present, the commonly used AMH detection method is enzyme-linked immunoassay (ELISA), and it has obtained the normal reference range for ovarian response. In recent years, with the development of detection technology, chemiluminescence immunoassay(CLIA) detection reagents have been successively used for the detection of AMH. However, there are few studies on the comparison of these two detection methods. The predictive value of the new method on ovarian response was lack. Therefore, by comparing the two methods of ELISA and CLIA detection of AMH levels in this study, the predictive value of poor ovarian response (the number of retrieved oocyte ≤ 3) and high response (the number of retrieved oocyte ≥ 15) in IVF/ICSI stimulation cycle was analyzed. In order to provide more reference basis for individualized COH, the AMH cutoff value of low and high ovarian response by the new method predicts was analyzed. At the same time, the prediction value of the two methods is compared to determine whether the new CLIA is suitable for clinical application.
Looking for future studies?
Notify Me20 year–45 year
Female
Observational
Changsha, Hunan, 410008, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ELISA kit detecting the serum AMH level
Other names: experimental group
CLIA method detecting the serum AMH level
Other names: control group
Time frame: the day of oocytes retrieved,about three months after AMH test
the poor ovarian response :the number of retrieved oocyte ≤ 3,the high ovarian response :the number of retrieved oocyte ≥ 15
Time frame: 34-36 hours after hCG trigger,about three months after AMH test
the number of oocytes retrieved after hCG trigger
Time frame: any day of the menstrual cycle, about three months after study starting
anti-muller hormone
Reproductive & Genetic Hospital of CITIC-Xiangya
Other
Predictive Value of New AMH Test Method for Ovarian Response in Patients With IVF/ICSI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06633120
AMH, Adnexal Diseases
Lone Tree, Colorado, United States
View Trial DetailsNCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial Details